Details:

Alternative Title:
Emerg Infect Dis
Personal Author:
Bukreyeva, Iryna ; Angoulvant, Adela ; Bendib, Inès ; Gagnard, Jean-Charles ; Bourhis, Jean-Henri ; ... More +
Bukreyeva, Iryna ; Angoulvant, Adela ; Bendib, Inès ; Gagnard, Jean-Charles ; Bourhis, Jean-Henri ; Dargère, Sylvie ; Bonhomme, Julie ; Thellier, Marc ; Gachot, Bertrand ; Wyplosz, Benjamin Less -
Description:
Enterocytozoon bieneusi microsporidiosis is an emerging disease in immunocompromised patients. We report 2 cases of this disease in allogeneic hematopoietic stem cell transplant patients successfully treated with fumagillin. Thrombocytopenia occurred but without major adverse events. Modifications of immunosuppression could be avoided when E. bieneusi is rapidly identified and fumagillin therapy is started promptly.
Subject:
[+]
Adult
Antifungal Agents
Cyclohexanes
Enterocytozoon
Fatty Acids, Unsaturated
Female
Hematopoietic Stem Cell Transplantation
Humans
Immunosuppressive Agents
Leukemia, Myeloid
Male
Microsporidiosis
Middle Aged
Mycophenolic Acid
Platelet Count
Prednisone
Sesquiterpenes
Thrombocytopenia
Treatment Outcome

Source:
Emerg Infect Dis. 23(6):1039-1041.
Pubmed ID:
28518017
Pubmed Central ID:
PMC5443440
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:7b74d70036550581502027def7ff783628787f65099cbf92748eb0462ccc0247
File Type:

Supporting Files

• 	16-1825-F.gif	gif
  	16-1825-F.jpg	jpeg
  	16-1825.nxml	bin

More +